104 related articles for article (PubMed ID: 17098703)
1. [The expression of pseudogene HMGA1L2 in thyroid lesions].
Wang GL; Zhang GC; Li F; Zhao J; Hu WH; Zhang JF; Yin XL; Guo CJ; Jiang JF; Liang WH
Yi Chuan; 2006 Nov; 28(11):1365-70. PubMed ID: 17098703
[TBL] [Abstract][Full Text] [Related]
2. Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction.
Bièche I; Franc B; Vidaud D; Vidaud M; Lidereau R
Thyroid; 2001 Feb; 11(2):147-52. PubMed ID: 11288983
[TBL] [Abstract][Full Text] [Related]
3. Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma.
Lin S; Meng W; Zhang W; Liu J; Wang P; Xue S; Chen G
J Int Med Res; 2013 Jun; 41(3):568-72. PubMed ID: 23685895
[TBL] [Abstract][Full Text] [Related]
4. MAGE-1, GAGE-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goiter.
Ruschenburg I; Kubitz A; Schlott T; Korabiowska M; Droese M
Int J Mol Med; 1999 Oct; 4(4):445-8. PubMed ID: 10493989
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells detected by reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA: distinguishing follicular thyroid carcinoma from adenoma.
Sato T; Harao M; Nakano S; Jotsuka T; Suda N; Yamashita J
Surgery; 2005 May; 137(5):552-8. PubMed ID: 15855928
[TBL] [Abstract][Full Text] [Related]
6. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.
Ermak G; Gerasimov G; Troshina K; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1995 Oct; 55(20):4594-8. PubMed ID: 7553635
[TBL] [Abstract][Full Text] [Related]
7. [Expression of motilin and its precursor mRNA in normal parenchyma, benign and malignant tumors of human thyroid].
Xu L; Zhong F; Guo FF; Zhao WJ; Sun XR; Wei XF
Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):243-9. PubMed ID: 18844033
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
[TBL] [Abstract][Full Text] [Related]
9. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction.
Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N
Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas.
Stolf BS; Carvalho AF; Martins WK; Runza FB; Brun M; Hirata R; Jordão Neves E; Soares FA; Postigo-Dias J; Kowalski LP; Reis LF
Cancer Lett; 2003 Mar; 191(2):193-202. PubMed ID: 12618333
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
13. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
[TBL] [Abstract][Full Text] [Related]
14. Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAF(V600E) Mutation and BRAF Pseudogene.
Lin JD; Fu SS; Chen JY; Lee CH; Chau WK; Cheng CW; Wang YH; Lin YF; Fang WF; Tang KT
Thyroid; 2016 May; 26(5):691-704. PubMed ID: 26914762
[TBL] [Abstract][Full Text] [Related]
15. Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene.
Duprez L; Hermans J; Van Sande J; Dumont JE; Vassart G; Parma J
J Clin Endocrinol Metab; 1997 Jan; 82(1):306-8. PubMed ID: 8989278
[No Abstract] [Full Text] [Related]
16. HMGA1-pseudogene expression is induced in human pituitary tumors.
Esposito F; De Martino M; D'Angelo D; Mussnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Trouillas J; Fusco A
Cell Cycle; 2015; 14(9):1471-5. PubMed ID: 25894544
[TBL] [Abstract][Full Text] [Related]
17. [From diffuse goiter to nodular goiter].
Derwahl M
Internist (Berl); 1998 Jun; 39(6):577-83. PubMed ID: 9677512
[No Abstract] [Full Text] [Related]
18. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
19. VEGFc and VEGFR3 expression in human thyroid pathologies.
Shushanov S; Bronstein M; Adélaïde J; Jussila L; Tchipysheva T; Jacquemier J; Stavrovskaya A; Birnbaum D; Karamysheva A
Int J Cancer; 2000 Apr; 86(1):47-52. PubMed ID: 10728593
[TBL] [Abstract][Full Text] [Related]
20. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.
Esposito F; De Martino M; Petti MG; Forzati F; Tornincasa M; Federico A; Arra C; Pierantoni GM; Fusco A
Oncotarget; 2014 Sep; 5(18):8341-54. PubMed ID: 25268743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
